These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].
    Author: Lommatzsch PK, Weise B, Ballin R.
    Journal: Klin Monbl Augenheilkd; 1986 Aug; 189(2):133-40. PubMed ID: 3761990.
    Abstract:
    Brachytherapy with 106Ru/106Rh necessitates protracted irradiation because the applicators have to be sutured to the sclera. Protracted radiotherapy causes more intensive damage in tumor cells with increased metabolism and a higher mitosis rate than in normal tissue. Beta irradiation of rabbit eyes with 0.258-0.231 Gy/min produced more extensive exudative reactions and morphological damage of the retina than a lower dosage rate with 0.035-0.026 Gy/min and the same total dose of 650 Gy. For the study reported here 75 patients suffering from choroidal melanoma and irradiated with 106Ru/106Rh plaques between 1967 and 1977 were evaluated. They developed more exudative and hemorrhagic side effects after a short period of irradiation (1-6 days) than after a longer one (7-14 days). Spontaneous recovery of the radiation-induced retinal detachment was seen in all cases. Complete tumor regression with development of a flat scar was achieved with almost equal success with both short-term and protracted irradiation. To minimize radiogenic side effects the duration of irradiation recommended hitherto, i.e., 7-14 days, should be adhered to when treating malignant melanomas of the choroid with beta-ray applicators.
    [Abstract] [Full Text] [Related] [New Search]